TERT and hepatocellular carcinoma: This provided preliminary evidence for the therapeutic potential of TERT inhibition in HCC.443,444 BIBR1532, a small molecule competitively blocking the active site of telomerase, has been linked to telomerase inhibition and HCC cell death in preclinical studies.445 However, there is no data in late phase clinical trials.